Internal Server Error

ONCOHOST - About the company

ONCOHOST is a series C company based in Binyamina Giv at Ada (Israel), founded in 2017 by Yuval Shaked and Ofer Sharon. It operates as an AI-based oncology therapy plan solution for professionals. ONCOHOST has raised $43M in funding from OurCrowd and ALIVE. The company has 762 active competitors, including 90 funded and 77 that have exited. Its top competitors include companies like Biodesix, Strand Life Sciences and OncoCyte.

Company Details

AI-based oncology therapy plan solution for patients and professionals. The company has developed a proprietary proteomic analysis that can analyze the proteomic changes in the blood sample induced by the patient in response to cancer therapy. The company also provide treatment strategy to improve the effectiveness of therapy. It also provides consultancy services to patients, oncologists, nurses, and pharma companies among others. The company has developed PROphet which is a bioinformatics tool used to identify proteomic patterns related to therapy.
Social
X
Phone Number
+972 **********
Key Metrics
Founded Year
2017
Location
Binyamina Giv at Ada, Israel
Stage
Series C
Total Funding
$43M in 4 rounds
Investors
Ranked
Employee Count
44 as on Jun 30, 2026
Similar Companies
Sign up to download ONCOHOST's company profile

ONCOHOST's funding and investors

ONCOHOST has raised a total funding of $43M over 4 rounds. Its first funding round was on Jan 21, 2020. Its latest funding round was a Grant (prize money) round on May 15, 2025 for $*****. 1 investor participated in its latest round. ONCOHOST has 7 institutional investors.

Here is the list of recent funding rounds of ONCOHOST:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
May 15, 2025
9379325
Grant (prize money)
5806051
8663079
9710262
1396736
May 10, 2022
3923584
Series C
1877978
5319588
1190685
Jan 19, 2021
5685055
Series B
9754045
1722130
6864260
lockAccess funding benchmarks and valuations. Sign up today!

ONCOHOST's founders and board of directors

Founder? Claim Profile
The founders of ONCOHOST are Yuval Shaked and Ofer Sharon. Ofer Sharon is the CEO of ONCOHOST.
Here are the details of ONCOHOST's key team members:

ONCOHOST's employee count trend

ONCOHOST has 44 employees as of Jun 26. Here is ONCOHOST's employee count trend over the years:
Employee count trend for ONCOHOST
lockUncover ONCOHOST's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

ONCOHOST's Competitors and alternates

Top competitors of ONCOHOST include Biodesix, Strand Life Sciences and OncoCyte. Here is the list of Top 10 competitors of ONCOHOST, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Biodesix
Biodesix
2005, Boulder (United States), Public
Developer of diagnostics assays for the detection of cancer
$200M
75/100
2nd
Logo for Strand Life Sciences
Strand Life Sciences
2000, Bengaluru (India), Acquired
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
$34.9M
73/100
3rd
Logo for OncoCyte
OncoCyte
2009, Irvine (United States), Public
Developer of non-invasive diagnostic tests solutions for the treatment of cancer
$15.3M
66/100
4th
Logo for BGI
BGI
1999, Shenzhen (China), Public
Provider of services in genome sequencing
-
64/100
5th
Logo for Hexagon Bio
Hexagon Bio
2017, Menlo Park (United States), Series B
Provider of bioinformatics tools for the analysis of microbial genomic sequencing data
$206M
63/100
6th
Logo for VieCure
VieCure
2015, Greenwood Village (United States), Series C
AI-based platform for generating oncology treatment plans
$113M
63/100
7th
Logo for ONCOHOST
ONCOHOST
2017, Binyamina Giv at Ada (Israel), Series C
AI-based oncology therapy plan solution for professionals
$43M
60/100
8th
Logo for Oxford Cancer Analytics
Oxford Cancer Analytics
2018, Oxford (United Kingdom), Series A
Provider of a platform for detection of lung cancer
$16.5M
60/100
9th
Logo for BostonGene
BostonGene
2015, Waltham (United States), Series B
Developer of cloud-based information and analytics platform to treat cancer
$200M
57/100
10th
Logo for Geneseeq
Geneseeq
2012, Toronto (Canada), Series D
Providing personalised cancer treatment solutions based on patients genomic profile
$128M
57/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on ONCOHOST's competitors? Click here to see the top ones

ONCOHOST's Investments and acquisitions

ONCOHOST has made no investments or acquisitions yet.

News related to ONCOHOST

lockFilter this list
Media has covered ONCOHOST for a total of 2 events in the last 1 year.
OncoHost partners with Gustave Roussy Cancer InstituteEuropean Pharmaceutical ManufacturerMar 03, 2025ONCOHOST, Gustave Roussy
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about ONCOHOST

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford